Suramin

This publication has 16 references indexed in Scilit:

• Suramin, an Active Drug for Prostate Cancer: Interim Observations in a Phase I Trial
  JNCI Journal of the National Cancer Institute, 1993
• Inhibitory effect of suramin on receptor binding and cytotoxic activity of tumor necrosis factor α
  International Journal of Immunopharmacology, 1992
• Suramin, an experimental chemotherapeutic drug, activates the receptor for epidermal growth factor and promotes growth of certain malignant cells.
  Journal of Clinical Investigation, 1992
• Suramin Blockade of Insulinlike Growth Factor I-Stimulated Proliferation of Human Osteosarcoma Cells
  JNCI Journal of the National Cancer Institute, 1990
• Suramin for prostatic cancer: A phase I/II study in advanced extensively pretreated disease
  European Journal of Cancer and Clinical Oncology, 1990
• Suramin, an anti‐cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A
  FEBS Letters, 1989
• Suramin therapy in AIDS and related disorders. Report of the US Suramin Working Group
  JAMA, 1987
• Suramin Protection of T Cells in Vitro Against Infectivity and Cytopathic Effect of HTLV-III
  Science, 1984
• The Population Approach to Pharmacokinetic Data Analysis: Rationale and Standard Data Analysis Methods
  Drug Metabolism Reviews, 1984
• Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses
  Cancer Letters, 1979